diazoxide has been researched along with Allergic Encephalomyelitis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biber, K; Espinosa-Parrilla, JF; Mancera, P; Pugliese, M; Sorrosal, G; Virgili, N; Wappenhans, B | 1 |
Chanvillard, C; Espinosa-Parrilla, JF; Infante-Duarte, C; Mancera, P; Pugliese, M; Rodríguez, MJ; Virgili, N; Wappenhans, B; Wegner, A | 1 |
Espinosa-Parrilla, JF; Gimeno-Bayon, J; Mahy, N; Mancera, P; Pastén-Zamorano, A; Pugliese, M; Rodríguez, MJ; Virgili, N | 1 |
Datko, LJ; Kassarich, J; Rosenthale, ME; Schneider, F | 1 |
4 other study(ies) available for diazoxide and Allergic Encephalomyelitis
Article | Year |
---|---|
K(ATP) channel opener diazoxide prevents neurodegeneration: a new mechanism of action via antioxidative pathway activation.
Topics: Animals; Antioxidants; Cell Line; Cell Survival; Cerebellum; Diazoxide; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Female; Hippocampus; Ion Channel Gating; KATP Channels; Mice; Microglia; Motor Neurons; Myelin Sheath; Neurodegenerative Diseases; Neuroprotective Agents; Neurotoxins; NF-E2-Related Factor 2; Oxidative Stress; Protein Transport; Rats; Spinal Cord | 2013 |
Diazoxide attenuates autoimmune encephalomyelitis and modulates lymphocyte proliferation and dendritic cell functionality.
Topics: Animals; Antigens, CD; B7-1 Antigen; B7-2 Antigen; CD4-Positive T-Lymphocytes; CD83 Antigen; Cells, Cultured; Dendritic Cells; Diazoxide; Encephalomyelitis, Autoimmune, Experimental; Female; Histocompatibility Antigens Class II; Immunoglobulins; Lymphocyte Activation; Membrane Glycoproteins; Mice; Spleen | 2014 |
Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Cell Line; Diazoxide; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Interferon-gamma; Interleukin-6; KATP Channels; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Nitrites; Tumor Necrosis Factor-alpha | 2011 |
Chemotherapy of experimental allergic encephalomyelitis (EAE).
Topics: Allopurinol; Aminocaproates; Analgesics; Animals; Antineoplastic Agents; Azathioprine; Body Weight; Chloroquine; Colchicine; Cortisone; Cyclophosphamide; Cyproheptadine; Diazoxide; Dimethyl Sulfoxide; Encephalomyelitis, Autoimmune, Experimental; Hydrocortisone; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Methyldopa; Nialamide; Oils; Organ Size; Rats; Strychnine; Talc; Thalidomide; Thioguanine; Thiomalates | 1969 |